Clinical trials: Childhood Rheumatic Diseases

Arthritis, Juvenile Idiopathic

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

• Completed
• Age: 2 to 17 years
• Phase 3
• Results posted

This study will evaluate the effect of etanercept on the clinical benefit, safety, and physical functioning (ability to function in daily life) in children and adolescent subjects with 3 subtypes of childhood arthritis.

Trial name

CLIPPER (NCT00962741)

Testing

Etanercept

Where

42 sites in Australia, Belgium and 17 more

Volunteers

127 people

Sponsor

Pfizer